Biomarck
![startup company logo](https://research.ncsu.edu/commercialization/files/2018/01/Biomarck_Pharmaceuticals_logo.png)
NC State Startup Biomarck Pharmaceuticals launches Phase 2 clinical trial for lung cancer treatment
![startup company logo](https://research.ncsu.edu/commercialization/files/2018/01/Biomarck_Pharmaceuticals_logo.png)
Child with Rare Cancer is First to Receive NC State Startup Biomarck Pharmaceuticals’ Drug
![startup company logo](https://research.ncsu.edu/commercialization/files/2018/01/Biomarck_Pharmaceuticals_logo.png)
Biomarck Pharmaceuticals Gains FDA Allowance to Begin Human Trials for Inhaled Treatment for Adults with Lung Cancer
![](https://research.ncsu.edu/commercialization/files/2020/07/Biomarck_2clr_horiz-260x63-1.png)